However, only a subset of α-syn, TDP-43 and tau mutations have been experimentally shown to increase aggregation potential while many other autosomal dominant disease mutations do not directly affect protein oligomerization [12–14] and yet, at least with TDP-43, nevertheless extend protein half-life [15, 16]. Here, TARDBP is linked to autosomal dominant disease.